Sirius Point entered a lost portfolio transfer agreement with Riverstone that should free over $200 million of capital upon completion, increase its BFCR ratio by approximately 20 points and reduce runoff exposures to de minimis levels, subject to regulatory approvals.
SPNT · SiriusPoint Ltd
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
SiriusPoint reported net income of $257.8 million for the nine months ended September 30, 2026, compared with $216.0 million for the nine months ended September 30, 2025.
SiriusPoint reported $87 million of net income available to common shareholders for the third quarter ended September 30, 2026, and a 90.1% core combined ratio. Its RiverStone loss portfolio transfer is expected to unlock over $200 million of capital, subject to regulatory approval.
SiriusPoint Ltd. appointed John Sauerland to its Board of Directors effective January 1, 2027. He brings more than 35 years of insurance industry experience and was most recently Chief Financial Officer at Progressive Insurance.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Jul 30, 2026TL;DR. SiriusPoint delivered Q2 2026 operating ROE of 13.8% and HY operating ROE of 14.7% at the upper end of its 12-15% target, with Insurance & Services GWP up 15% offset by Reinsurance GWP down 9%, returning $295m of capital year-to-date.
- + Operating ROE of 14.7% for HY 2026 sits at the upper end of the 12-15% target range
- + Insurance & Services GWP grew 15% in Q2 and 11% year-to-date
- + Net income available to common shareholders up 44% to $168m for HY 2026
- + Book value per diluted common share ex. AOCI rose 8% YTD to $19.48
- + Core combined ratio improved 2.3 points to 90.1% in HY 2026
- + $295m of capital returned to shareholders year-to-date including $95m of share repurchases
- − Reinsurance GWP declined 9% in Q2 and HY as the company pulled back from unattractive pricing
- − Net earned premium was reduced by approximately 10% or $31m in Q2 due to a shift in business mix toward longer-duration lines
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Insurance - Reinsurance — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SPNT
this stock
SiriusPoint Ltd
|
$3.04B | +20.7% | +23.1% | 6.5 | 4.6% |
|
RGA
Reinsurance Group Of America Inc
|
$17.68B | +33.6% | +7.2% | 10.5 | 1.5% |
|
EG
Everest Group, Ltd.
|
$16.04B | +27.6% | +1.2% | 9.2 | 4.1% |
|
RNR
Renaissancere Holdings Ltd
|
$14.41B | +26.8% | +9.9% | 5.9 | 2.9% |
|
HG
Hamilton Insurance Group, Ltd.
|
$2.56B | +38.5% | +24.7% | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 5, 2026
- This year
- 18
SiriusPoint reported $87 million of net income available to common shareholders for the third quarter ended September 30, 2026, and a 90.1% core combined ratio. Its RiverStone loss portfolio transfer is expected to unlock over $200 million of capital, subject to regulatory approval.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SPNT | +0.0% | +4.8% | +17.2% | +2.1% | +20.7% |
| SPY | -1.7% | -3.5% | -1.4% | -2.1% | +8.5% |
| vs SPY | +1.7% | +8.3% | +18.6% | +4.2% | +12.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.